China’s Hua Medicine plans $400 million Hong Kong IPO, led by Goldman: sources

HONG KONG (Reuters) – Chinese drug developer Hua Medicine is planning to raise at least $400 million in an initial public offer in Hong Kong in the latest in a series of biotech floats in the city, said people with knowledge of the matter. Hong Kong is …
( read original story …)


Related Post

250 live geckos from Hong Kong seized by Customs a...
views 10
MANILA, Philippines — The Bureau of Customs (BOC) ...
Losses May Accelerate For Hong Kong Stock Market
views 11
Among the actives, China Petroleum and Chemical (S...
Hong Kong Bourse Tipped To Open Higher
views 10
BOC Hong Kong skidded 0.89 percent, New World Deve...
Man Who Bared `Enigma Network’ Has New Hong ...
views 18
(Bloomberg) -- His last big warning to investors, ...
Alibaba-backed Hong Kong AI lab names first batch ...
views 17
A Hong Kong artificial intelligence lab backed by ...
Briefing: Alibaba and SenseTime-backed Hong Kong A...
views 17
What happened: A Hong Kong artificial intelligence...
Hong Kong: HANG SENG INDEX (.HSI) little changed e...
views 23
After Wednesday’s holiday and strong regional gain...
Hong Kong man sentenced to 1 year in jail for voye...
views 22
Lap Kwan Yue, 19, will spend one year behind bars....
Hong Kong Vs. Singapore: Which Stock Market Has Be...
views 23
So how can it be that the HSI so handily outperfor...
Tencent partners with HK property developer SHKP t...
views 24
Internet giant Tencent Holdings Ltd and Hong Kong ...